Vyome Holdings, Inc. (HIND)
$2.01-3.83%Close
SELLRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14M
- Beta
- 1.54
- P/E (TTM)
- -0.07
- Short % float
- 1.30%
- Days to cover
- 1.0
- SI change
- +21.9%
- 1W
- +4.15%
- 1M
- -2.43%
- vs SPY 1W
- +3.72%
- vs SPY 1M
- -4.49%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on HIND?
- LOPJLB’s latest quantitative signal on Vyome Holdings, Inc. (HIND) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is HIND in?
- Vyome Holdings, Inc. (HIND) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Vyome Holdings, Inc. (HIND) do?
- Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.